We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasonic Screening May Provide More Effective Breast Cancer Detection

By MedImaging International staff writers
Posted on 21 Mar 2012
Print article
Scientists have successfully completed an initial trial of a new, potentially more effective, technique for screening breast cancer using ultrasound.

The team, from the National Physical Laboratory (NPL; Teddington, Middlesex, UK), the UK’s National Measurement Institute, working with the University Hospitals Bristol NHS [National Health Service] Foundation Trust, are now looking to develop the technique into a clinical device.

Annually, 46,000 women are diagnosed with breast cancer in the United Kingdom, cutting-edge breast screening methods, based on X-ray mammography. Only approximately 30% of suspicious lesions turn out to be malignant. Each lesion must be confirmed by invasive biopsies, estimated to cost the NHS GBP 35 million per year. Ionizing radiation also has the potential to cause cancer, which limits the use of X-rays to single screenings of at risk groups, such as women over 50 through the National Breast Screening Program.

There is a compelling need to develop improved, ideally nonionizing, methods of detecting breast lesions and solid masses. Improved diagnosis would reduce unnecessary biopsies and consequent patient trauma from being wrongly diagnosed.

Ultrasound fulfills many of the requirements it is safe, low cost, and already extensively used in applications such as fetal scanning. However, the quality of the images is not yet good enough for reliable diagnoses. Part of the difficulty lies with the current detectors used. Different biologic tissues have different sound speeds, and this affects the time taken for sound waves to arrive at the detector. This can distort the arriving waves, in extreme cases causing cancellation them to cancel each other out. This results in imaging errors, such as suggesting abnormal inclusions where there may be none.

The new method works by detecting the intensity of ultrasonic waves. Intensity is converted to heat that is then sensed by a thin membrane of pyroelectric film, which generates a voltage output dependent on the temperature rise. Imaging detectors based on this new principle should be much less susceptible to the effects caused by the uneven sound speed in tissues.

This technique, when used in a computed tomography (CT) configuration, should produce more accurate images of tissue properties and so provide better identification of breast tissue abnormalities. The goal of CT imaging is to generate a cross-section map of the tissue, which defines how the acoustic characteristics vary across the tissue. Using this map, it is possible to identify abnormal inclusions.

An initial feasibility project has proved the theory by testing single detectors using purpose-built artifacts. These artifacts were designed to include well-defined structures, enabling the new imaging technique to be compared with more conventional techniques. The findings validated that the new detectors generated more effective maps of the internal structure of the artifacts than existing techniques.

Having received positive findings and validated the potential of the project, NPL is now seeking funding to develop the work further. They hope to produce a demonstrator using a full array of 20 sensors, which should allow more rapid scanning and move the concept towards a system, which might eventually be used clinically. It is hoped that this will provide both a suitable resolution and fast enough scanning to become a viable replacement for current clinical scanners. Following successful completion of the demonstrator, NPL and partners will look to work with a manufacturer to commercialize the technology.

Dr. Bajram Zeqiri, who leads the project at the National Physical Laboratory, said, “Our initial results are very promising. […] we’re very excited about its potential and with the right funding, support, and industry partners, we may well have something here which could have a huge and positive impact on cancer diagnosis and the lives of many thousands of women.”

Related Links:
UK National Physical Laboratory


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Compact C-Arm
Arcovis DRF-C S21
Ultrasound Doppler System
Doppler BT-200
New
Digital Radiography Generator
meX+20BT lite

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.